tiprankstipranks
Cullinan Management (CGEM)
NASDAQ:CGEM
US Market
Want to see CGEM full AI Analyst Report?

Cullinan Management (CGEM) Stock Forecast & Price Target

349 Followers
See the Price Targets and Ratings of:

CGEM Analyst Ratings

Strong Buy
11Ratings
Strong Buy
11 Buy
0 Hold
0 Sell
Based on 11 analysts giving stock ratings to
Cullinan
Management
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

CGEM Stock 12 Month Forecast

Average Price Target

$30.00
▲(99.20% Upside)
Based on 11 Wall Street analysts offering 12 month price targets for Cullinan Management in the last 3 months. The average price target is $30.00 with a high forecast of $38.00 and a low forecast of $14.00. The average price target represents a 99.20% change from the last price of $15.06.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"5":"$5","22":"$22","39":"$39","13.5":"$13.5","30.5":"$30.5"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":38,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$38.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":30,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$30.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":14,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$14.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[5,13.5,22,30.5,39],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Aug<br/>2025","6":"Nov<br/>2025","9":"Feb<br/>2026","12":"May<br/>2026","25":"May<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,13.43,15.32,17.21,19.1,20.990000000000002,22.880000000000003,24.77,26.66,28.55,30.44,32.33,34.22,36.11,{"y":38,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,13.43,14.704615384615384,15.97923076923077,17.253846153846155,18.52846153846154,19.803076923076922,21.07769230769231,22.352307692307694,23.626923076923077,24.90153846153846,26.176153846153845,27.450769230769232,28.725384615384616,{"y":30,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,13.43,13.473846153846154,13.517692307692307,13.561538461538461,13.605384615384615,13.649230769230769,13.693076923076923,13.736923076923077,13.78076923076923,13.824615384615385,13.868461538461538,13.912307692307692,13.956153846153846,{"y":14,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":8.52,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":8.75,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 24,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":7.64,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 21,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":7.67,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 23,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":7.49,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 21,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":6,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 25,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":8.66,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 27,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":10.75,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 27,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":10.35,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 25,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":12.71,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":15.99,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":13.94,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":13.43,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 21,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target$38.00Average Price Target$30.00Lowest Price Target$14.00
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
UBS
$24
Buy
59.36%
Upside
Reiterated
05/14/26
Analysts Conflicted on These Healthcare Names: Cullinan Management (NASDAQ: CGEM), Humacyte (NASDAQ: HUMA) and Revvity (NYSE: RVTY)
H.C. Wainwright Analyst forecast on CGEM
H.C. Wainwright
H.C. Wainwright
$30
Buy
99.20%
Upside
Reiterated
05/11/26
Wall Street Analysts Are Bullish on Top Healthcare Picks
Stifel Nicolaus Analyst forecast on CGEM
Stifel Nicolaus
Stifel Nicolaus
$28
Buy
85.92%
Upside
Reiterated
05/08/26
Analysts' Opinions Are Mixed on These Healthcare Stocks: Tectonic Therapeutic (NASDAQ: TECX), Cullinan Management (NASDAQ: CGEM) and Siemens Healthineers AG (Other OTC: SEMHF)
Wedbush
$36$37
Buy
145.68%
Upside
Reiterated
05/08/26
Cullinan Management (CGEM) Receives a Buy from Wedbush
BTIG
$38
Buy
152.32%
Upside
Reiterated
05/07/26
Cullinan Management (CGEM) Receives a Rating Update from a Top Analyst
TD Cowen Analyst forecast on CGEM
TD Cowen
TD Cowen
Buy
Reiterated
05/07/26
Analysts' Top Healthcare Picks: Cullinan Management (CGEM), Neumora Therapeutics, Inc. (NMRA)
William Blair Analyst forecast on CGEM
William Blair
William Blair
$14
Buy
-7.04%
Downside
Reiterated
05/07/26
Wall Street Analysts Are Bullish on Top Healthcare Picks
JonesTrading Analyst forecast on CGEM
JonesTrading
JonesTrading
$36
Buy
139.04%
Upside
Reiterated
05/06/26
JonesTrading Remains a Buy on Cullinan Management (CGEM)
Morgan Stanley Analyst forecast on CGEM
Morgan Stanley
Morgan Stanley
$30
Buy
99.20%
Upside
Reiterated
03/16/26
Morgan Stanley Sticks to Their Buy Rating for Cullinan Management (CGEM)
Guggenheim Analyst forecast on CGEM
Guggenheim
Guggenheim
$30
Buy
99.20%
Upside
Reiterated
03/10/26
Guggenheim Reaffirms Their Buy Rating on Cullinan Management (CGEM)
Citi
$33
Buy
119.12%
Upside
Initiated
02/18/26
Cullinan Oncology: Undervalued Autoimmune Pipeline With 2026 CLN-978 Catalysts and Additional Oncology Upside Supporting Buy Rating
Clear Street Analyst forecast on CGEM
Clear Street
Clear Street
$22$33
Buy
119.12%
Upside
Reiterated
12/10/25
Cullinan Therapeutics price target raised to $33 from $22 at Clear StreetCullinan Therapeutics price target raised to $33 from $22 at Clear Street
Leerink Partners Analyst forecast on CGEM
Leerink Partners
Leerink Partners
Buy
Reiterated
09/04/25
Cullinan Management's Strategic Adjustments and Pipeline Development Justify Buy Rating
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
UBS
$24
Buy
59.36%
Upside
Reiterated
05/14/26
Analysts Conflicted on These Healthcare Names: Cullinan Management (NASDAQ: CGEM), Humacyte (NASDAQ: HUMA) and Revvity (NYSE: RVTY)
H.C. Wainwright Analyst forecast on CGEM
H.C. Wainwright
H.C. Wainwright
$30
Buy
99.20%
Upside
Reiterated
05/11/26
Wall Street Analysts Are Bullish on Top Healthcare Picks
Stifel Nicolaus Analyst forecast on CGEM
Stifel Nicolaus
Stifel Nicolaus
$28
Buy
85.92%
Upside
Reiterated
05/08/26
Analysts' Opinions Are Mixed on These Healthcare Stocks: Tectonic Therapeutic (NASDAQ: TECX), Cullinan Management (NASDAQ: CGEM) and Siemens Healthineers AG (Other OTC: SEMHF)
Wedbush
$36$37
Buy
145.68%
Upside
Reiterated
05/08/26
Cullinan Management (CGEM) Receives a Buy from Wedbush
BTIG
$38
Buy
152.32%
Upside
Reiterated
05/07/26
Cullinan Management (CGEM) Receives a Rating Update from a Top Analyst
TD Cowen Analyst forecast on CGEM
TD Cowen
TD Cowen
Buy
Reiterated
05/07/26
Analysts' Top Healthcare Picks: Cullinan Management (CGEM), Neumora Therapeutics, Inc. (NMRA)
William Blair Analyst forecast on CGEM
William Blair
William Blair
$14
Buy
-7.04%
Downside
Reiterated
05/07/26
Wall Street Analysts Are Bullish on Top Healthcare Picks
JonesTrading Analyst forecast on CGEM
JonesTrading
JonesTrading
$36
Buy
139.04%
Upside
Reiterated
05/06/26
JonesTrading Remains a Buy on Cullinan Management (CGEM)
Morgan Stanley Analyst forecast on CGEM
Morgan Stanley
Morgan Stanley
$30
Buy
99.20%
Upside
Reiterated
03/16/26
Morgan Stanley Sticks to Their Buy Rating for Cullinan Management (CGEM)
Guggenheim Analyst forecast on CGEM
Guggenheim
Guggenheim
$30
Buy
99.20%
Upside
Reiterated
03/10/26
Guggenheim Reaffirms Their Buy Rating on Cullinan Management (CGEM)
Citi
$33
Buy
119.12%
Upside
Initiated
02/18/26
Cullinan Oncology: Undervalued Autoimmune Pipeline With 2026 CLN-978 Catalysts and Additional Oncology Upside Supporting Buy Rating
Clear Street Analyst forecast on CGEM
Clear Street
Clear Street
$22$33
Buy
119.12%
Upside
Reiterated
12/10/25
Cullinan Therapeutics price target raised to $33 from $22 at Clear StreetCullinan Therapeutics price target raised to $33 from $22 at Clear Street
Leerink Partners Analyst forecast on CGEM
Leerink Partners
Leerink Partners
Buy
Reiterated
09/04/25
Cullinan Management's Strategic Adjustments and Pipeline Development Justify Buy Rating
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Cullinan Management

3 Months
xxx
Success Rate
8/13 ratings generated profit
62%
Average Return
+13.31%
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 61.54% of your transactions generating a profit, with an average return of +13.31% per trade.
1 Year
Matt PhippsWilliam Blair
Success Rate
10/13 ratings generated profit
77%
Average Return
+50.58%
Copying Matt Phipps's trades and holding each position for 1 Year would result in 76.92% of your transactions generating a profit, with an average return of +50.58% per trade.
2 Years
xxx
Success Rate
10/13 ratings generated profit
77%
Average Return
+53.38%
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 76.92% of your transactions generating a profit, with an average return of +53.38% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

CGEM Analyst Recommendation Trends

Rating
Jan 26
Feb 26
Mar 26
Apr 26
May 26
Strong Buy
20
14
12
12
15
Buy
5
2
2
3
6
Hold
0
0
0
0
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
25
16
14
15
21
In the current month, CGEM has received 21 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. CGEM average Analyst price target in the past 3 months is 30.00.
Each month's total comprises the sum of three months' worth of ratings.

CGEM Financial Forecast

CGEM Earnings Forecast

Next quarter’s earnings estimate for CGEM is -$0.80 with a range of -$1.00 to -$0.26. The previous quarter’s EPS was -$0.75. CGEM beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year CGEM has Performed in-line its overall industry.
Next quarter’s earnings estimate for CGEM is -$0.80 with a range of -$1.00 to -$0.26. The previous quarter’s EPS was -$0.75. CGEM beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year CGEM has Performed in-line its overall industry.
No data currently available

CGEM Sales Forecast

Next quarter’s sales forecast for CGEM is $0.00 with a range of $0.00 to $0.00. The previous quarter’s sales results were $0.00. CGEM beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year CGEM has Performed in-line its overall industry.
Next quarter’s sales forecast for CGEM is $0.00 with a range of $0.00 to $0.00. The previous quarter’s sales results were $0.00. CGEM beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year CGEM has Performed in-line its overall industry.

CGEM Stock Forecast FAQ

What is CGEM’s average 12-month price target, according to analysts?
Based on analyst ratings, Cullinan Management’s 12-month average price target is 30.00.
    What is CGEM’s upside potential, based on the analysts’ average price target?
    Cullinan Management has 99.20% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is CGEM a Buy, Sell or Hold?
          Cullinan Management has a consensus rating of Strong Buy which is based on 11 buy ratings, 0 hold ratings and 0 sell ratings.
            What is Cullinan Management’s price target?
            The average price target for Cullinan Management is 30.00. This is based on 11 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst price target is $38.00 ,the lowest forecast is $14.00. The average price target represents 99.20% Increase from the current price of $15.06.
              What do analysts say about Cullinan Management?
              Cullinan Management’s analyst rating consensus is a Strong Buy. This is based on the ratings of 11 Wall Streets Analysts.
                How can I buy shares of CGEM?
                Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.